
|Articles|January 25, 2021
Calyx ACTIVATEs CRO Partnership Program
Advertisement
Calyx has announced a new partnership program for Clinical Research Organizations (CROs). The program, “ACTIVATE Solutions for CRO Partners,” is designed to provide alignment between Calyx and its CRO partners.
Those who qualify to participate in ACTIVATE operate under a personalized governance and reporting structure that provides access to technology, decision-making, and issue resolution aiming to generate faster trial execution.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5




